Dr. Sabels research interests focus on the immune response to cancer cell death, particularly after cryoablation (freezing) of cancer, and he is an internationally recognized expert in the field of cryo-immunology. He also has several clinical trials examining cryoablation of breast cancer. Dr. Sabels lab is also focused on the identification of prognostic and predictive markers in oncology, using both serum proteomic and tissue microarray approaches, to help guide surgical and adjuvant therapy. Additionally, Dr. Sabel is interested in the use of mobile technologies to improve patient-physician communication and improve outcomes. He is the creator of two present apps; UMSkinCheck for self skin exam and early melanoma detection, and BreastCancerAlly, a mobile patient navigator app for patients with breast cancer, with several more in development.